MGTA - Magenta Therapeutics EPS beats by $0.03 November, 04 2021 09:22 AM Magenta Therapeutics Inc. Magenta Therapeutics (NASDAQ:MGTA): Q3 GAAP EPS of -$0.30 beats by $0.03. Cash, cash equivalents and marketable securities of $192.62M. Press Release For further details see: Magenta Therapeutics EPS beats by $0.03